Here are the latest quarterly results of BALAXI PHARMA. For more details, see the BALAXI PHARMA financial fact sheet and BALAXI PHARMA share price. For a sector overview, read our pharmaceuticals sector report.
No. of Mths Qtr. Ending |
3
Mar-21* |
3
Jun-21* |
3
Sep-21* |
3
Dec-21* |
3
Mar-22* |
3
Jun-22* |
3
Sep-22* |
3
Dec-22* |
8-Qtr Chart Click to enlarge |
|
---|---|---|---|---|---|---|---|---|---|---|
Net Sales | Rs m | 530 | 583 | 702 | 617 | 891 | 828 | 864 | 866 | |
Other income | Rs m | -3 | 12 | 1 | -4 | 41 | 33 | 41 | -46 | |
Turnover | Rs m | 527 | 595 | 704 | 613 | 932 | 861 | 905 | 820 | |
Expenses | Rs m | 426 | 469 | 562 | 482 | 779 | 690 | 716 | 713 | |
Gross profit | Rs m | 103 | 114 | 140 | 136 | 112 | 137 | 148 | 153 | |
Depreciation | Rs m | 1 | 1 | 1 | 2 | 2 | 2 | 2 | 2 | |
Interest | Rs m | 0 | 0 | 0 | 0 | 1 | 2 | 0 | 0 | |
Profit before tax | Rs m | 100 | 125 | 140 | 130 | 150 | 166 | 187 | 105 | |
Tax | Rs m | 16 | 18 | 20 | 8 | 23 | 25 | 32 | 23 | |
Profit after tax | Rs m | 84 | 107 | 121 | 122 | 127 | 141 | 155 | 82 | |
Gross profit margin | % | 19.5 | 19.5 | 20.0 | 22.0 | 12.6 | 16.6 | 17.1 | 17.7 | |
Effective tax rate | % | 16.1 | 14.2 | 14.1 | 6.1 | 15.4 | 15.0 | 17.1 | 21.8 | |
Net profit margin | % | 15.8 | 18.4 | 17.2 | 19.7 | 14.3 | 17.1 | 17.9 | 9.5 | |
Diluted EPS | Rs | 8.3 | 10.7 | 12.0 | 12.2 | 12.7 | 14.1 | 15.4 | 8.2 | |
Diluted EPS (TTM) | Rs | 38.0 | 40.0 | 42.0 | 43.2 | 47.5 | 51.0 | 54.4 | 50.4 | |
![]() |
Asian share markets are higher today in cautious trading after disappointing earnings from some big-tech names weighed on sentiment following a surge in US equities.